Vimarsana
Biggest News Aggregation in the World

Tuberous Sclerosis Complex News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tuberous Sclerosis Complex. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tuberous Sclerosis Complex Today - Breaking & Trending Today

Netherlands' medicines shortage bigger than ever - Vimarsana News

Netherlands' medicines shortage bigger than ever

The Netherlands’ medicines shortage is greater than ever, according to figures from the pharmacy organization KNMP. Last year, 2,292 medicines were unavailable nationwide for two or more weeks, compared to 1,514 in 2022. About 5 million of the 13 million medicine users in the Netherlands were affected by at least one medicine shortage last year, according to the KNMP. The medicine shortages have a major impact on patients.

Source: nltimes.nl
Cannabis-based drug launched to treat epilepsy in children - Vimarsana News

Cannabis-based drug launched to treat epilepsy in children

Akumentis Healthcare said its new drug is effective in reducing seizures especially where conventional antiseizure medications have proven ineffective

Noema Pharma to Present at Two Upcoming Conferences - Vimarsana News

Noema Pharma to Present at Two Upcoming Conferences

BASEL, Switzerland, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders, today announced that members of management will attend and present at two upcoming conferences in San Francisco, CA. SACHS 7th Annual Neuroscience Innovation ForumFormat: Panel DiscussionTitle: Exploring New Modalities for Rare & Orphan Neurological DiseasesDate: Sunday, January 7, 2024 Time: 11:00 a.m. PST (2:00 p.m. EST/8:00 p.m. CE

Source: yahoo.com
Piper Sandler Cuts Aadi Bioscience's Price Target to $5 From $30, Keeps Overweight Rating - Vimarsana News

Piper Sandler Cuts Aadi Bioscience's Price Target to $5 From $30, Keeps Overweight Rating

-- Price: 2.32, Change: -3.05, Percent Change: -56.80 ...

HC Wainwright Downgrades Aadi Bioscience to Neutral From Buy - Vimarsana News

HC Wainwright Downgrades Aadi Bioscience to Neutral From Buy

-- Price: 2.78, Change: -2.59, Percent Change: -48.23 ...